Does FILGRASTIM-SNDZ Cause Neoplasm malignant? 62 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 62 reports of Neoplasm malignant have been filed in association with FILGRASTIM-SNDZ. This represents 3.6% of all adverse event reports for FILGRASTIM-SNDZ.
62
Reports of Neoplasm malignant with FILGRASTIM-SNDZ
3.6%
of all FILGRASTIM-SNDZ reports
23
Deaths
2
Hospitalizations
How Dangerous Is Neoplasm malignant From FILGRASTIM-SNDZ?
Of the 62 reports, 23 (37.1%) resulted in death, 2 (3.2%) required hospitalization, and 1 (1.6%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FILGRASTIM-SNDZ. However, 62 reports have been filed with the FAERS database.
What Other Side Effects Does FILGRASTIM-SNDZ Cause?
Death (505)
White blood cell count decreased (79)
Hospitalisation (68)
Bone pain (61)
Pain (39)
Malaise (38)
Pyrexia (38)
Fatigue (37)
Drug ineffective (32)
Dyspnoea (30)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which FILGRASTIM-SNDZ Alternatives Have Lower Neoplasm malignant Risk?
FILGRASTIM-SNDZ vs FINASTERIDE
FILGRASTIM-SNDZ vs FINASTERIDE\TAMSULOSIN
FILGRASTIM-SNDZ vs FINERENONE
FILGRASTIM-SNDZ vs FINGOLIMOD
FILGRASTIM-SNDZ vs FINGOLIMOD LAURYL